KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Esperion Therapeutics (ESPR) Enterprise Value: 2013-2024

Historic Enterprise Value for Esperion Therapeutics (ESPR) over the last 12 years, with Dec 2024 value amounting to $288.7 million.

  • Esperion Therapeutics' Enterprise Value rose 146.77% to $441.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $96.4 million, marking a year-over-year increase of 130.21%. This contributed to the annual value of $288.7 million for FY2024, which is 12.01% up from last year.
  • As of FY2024, Esperion Therapeutics' Enterprise Value stood at $288.7 million, which was up 12.01% from $257.8 million recorded in FY2023.
  • In the past 5 years, Esperion Therapeutics' Enterprise Value ranged from a high of $419.8 million in FY2020 and a low of -$113.9 million during FY2021.
  • Moreover, its 3-year median value for Enterprise Value was $288.7 million (2024), whereas its average is $279.6 million.
  • Per our database at Business Quant, Esperion Therapeutics' Enterprise Value crashed by 127.14% in 2021 and then skyrocketed by 356.43% in 2022.
  • Over the past 5 years, Esperion Therapeutics' Enterprise Value (Yearly) stood at $419.8 million in 2020, then plummeted by 127.14% to -$113.9 million in 2021, then surged by 356.43% to $292.2 million in 2022, then declined by 11.78% to $257.8 million in 2023, then rose by 12.01% to $288.7 million in 2024.